Two early-phase clinical trials demonstrate the safety and potential clinical utility of stem cell therapies to ease motor ...

Key Takeaways Common drugs used to treat chronic ailments appear to delay the onset of Parkinson’s symptomsAspirin, ibuprofen, statins and beta blockers were all associated with a delay in Parkinson’s ...

Two new studies suggest that Parkinson's disease can potentially be treated with stem cells placed in a patient's brain.

The phase I clinical trials showed stem cell transplants for Parkinson’s disease appear to be safe and might restore dopamine-producing brain cells.

In a new Cedars-Sinai study of Parkinson's disease patients, those who had taken common medications to control pain, blood ...

Reacting to the findings of the trials, which have been published in the journal Nature, Claire Bale, associate director of ...

Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

The Killion family of Birmingham has given a $10 million gift to UAB to create the Wayne Killion Endowment for the Center for ...

The highly selective partial agonist at D1 and D5 receptors significantly improves motor function in patients recently ...

Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might ...

which could lead to treatments for the cognitive symptoms of Parkinson's ... New Drug Targets for Alzheimer's Identified from Cerebrospinal Fluid Nov. 14, 2024 — Researchers have linked disease ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...